Bio-Rad Laboratories, Inc.
- Last sale
- Nov 12, 2026 · -3.96%
- Market cap
- $9.60B
- 26.89M shares
- Filings
- 1,030
Q3 2026+0.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−82.5% FY25 yoy
Q3 2026derived+29.4% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+8.5% FY25 yoy
- $9.60B
- 9.4×
- 3.7×
- 1.3×
- 3.43%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,583,200,000 | reported | |
| FY 2024 | 2024-12-31 | $2,566,500,000 | reported | |
| FY 2023 | 2023-12-31 | $2,671,200,000 revised | reported | |
| FY 2022 | 2022-12-31 | $2,802,200,000 | reported | |
| FY 2021 | 2021-12-31 | $2,922,500,000 | reported | |
| FY 2020 | 2020-12-31 | $2,545,600,000 | reported | |
| FY 2019 | 2019-12-31 | $2,311,700,000 | reported | |
| FY 2018 | 2018-12-31 | $2,289,400,000 | reported | |
| FY 2017 | 2017-12-31 | $2,160,200,000 | reported | |
| FY 2016 | 2016-12-31 | $2,068,200,000 | reported | |
| FY 2015 | 2015-12-31 | $2,019,441,000 | reported | |
| FY 2014 | 2014-12-31 | $2,175,044,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $295.50M | $295.50M | — | — | — | 78.9% |
| FY2024 | — | $203.60M | $203.60M | — | — | — | 70.3% |
| FY2023 | — | $428.70M | $428.70M | — | — | — | 196.5% |
| FY2022 | — | $215.70M | $215.70M | — | — | — | 264.3% |
| FY2021 | — | $50.00M | $50.00M | — | — | — | 9.3% |
Segments
LineFY2023ShareChange
Clinical Diagnostics$1.49B56%+2.6%
Life Science$1.18B44%−12.5%
All Other Segments$3.60M0.1%−10.0%
Total$2.67B
Laboratory analytical instruments
Bio-Rad Laboratories, Inc. is the 8th largest of the 25 covered companies the SEC files under this code, by revenue. SIC 3826
CompanyRevenueGrowthNet marginMarket cap
AAgilent Technologies, Inc.$6.9B6.7%18.8%$48.8BAVTRAvantor, Inc.$6.6B3.4%8.1%$10.8BILMNIllumina, Inc.$4.3B0.7%19.6%$31.7BMTDMettler Toledo International Inc$4.0B4.0%21.6%$34.4BBRKRBruker Corp$3.4B2.1%0.3%$9.2BWATWaters Corp$3.2B7.0%20.3%$45.4BRVTYRevvity, Inc.$2.9B3.7%8.4%$17.5B
BIOBio-Rad Laboratories, Inc. (this company)$2.6B0.7%29.4%$9.6B
TXG10x Genomics, Inc.$642.8M5.2%6.8%$7.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR